Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study

Respir Med. 2018 Sep:142:1-6. doi: 10.1016/j.rmed.2018.07.003. Epub 2018 Jul 9.

Abstract

Background and objectives: Lung resection in patients with nontuberculous mycobacterial pulmonary disease (NTM-PD) is considered when medical therapy alone fails to provide long term control. Data regarding comparative and long-term outcomes are limited. We aimed to review indications and outcomes of adjuvant lung resection for NTM-PD compared with controls.

Methods: We retrospectively studied 27 surgically treated patients, matched 1:1 for age, sex, NTM species, and radiologic pattern of disease, with control patients treated exclusively with antibiotics.

Results: In the surgical group, the median (IQR) age was 55 (49-61) years and 74.1% were female. Eighteen patients had Mycobacterium avium complex, and 9 had M. xenopi. Operations included 8 pneumonectomies, 20 lobectomies, one segmentectomy and one lobectomy plus segmentectomy. Post-surgical complications occurred in 6 patients (20%), including 2 acute respiratory distress syndrome, 1 bronchopleural fistula, 1 pericardial tamponade, and 2 empyema. Complications were more common among patients operated upon for progressive disease despite medical therapy (OR 10, p = 0.025). Of 24 matched pairs followed for ≥1 year, sustained culture conversion was observed in 21 (87.5%) patients in the surgical group and in 11 (45.8%) patients in the non-surgical group (RR 2.36, 95%CI 1.37-4.03, p = 0.002). Median (IQR) percentage of follow-up time on antibiotics was 14% (0-100%) in the surgical group and 83% (10.8%-100%) in the non-surgical group (p = 0.195) during a median (IQR) follow-up of 16 (2-36) months.

Conclusions: NTM-PD patients who underwent adjuvant lung resection experienced significant morbidity and more frequently achieved sputum culture conversion. Long term antibiotic requirements may have been reduced.

Keywords: Mycobacterium avium-Intracellulare; Mycobacterium xenopi; Nontuberculous mycobacteria; Thoracic surgery; Treatment outcome.

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Cohort Studies
  • Combined Modality Therapy
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Mycobacterium Infections, Nontuberculous / therapy*
  • Pneumonectomy* / methods
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome
  • Tuberculosis, Pulmonary / therapy*

Substances

  • Anti-Bacterial Agents